“The right data to develop or validate a useful product depends on precisely understanding how it will be used, how it fits in existing clinical workflows, and its benefits to care providers and patients. 

The DiMe CRS initiative brought together a diverse group of stakeholders to understand these perspectives better, providing invaluable insights about the types of data we need to gather to tackle immunotherapy patient monitoring. We will work closely with our partners and employ digital products to transform clinical research, gathering the right data to empower care providers and patients alike in this space.”

– Michael Pettinati | Senior Data Scientist, ActiGraph